Not Tagged
Not Tagged
['cll']
at #ash22, our collaborators will present data using clonoseq to monitor mrd, reinforcing the value of mrd as one of the strongest measures of pt outcomes in lymphoid cancers. clonoseq is fda-cleared to assess mrd in cll, mm and b-all. for further info: 
The FDA-cleared clonoSEQ Assay from @AdaptiveBiotech detects and tracks MRD in patients w/ myeloma, B-ALL, or CLL. Policies: https://t.co/6zaCbi4pmE.